March 6, 2024Open Access

Microplastics and Nanoplastics in Atheromas and Cardiovascular Events

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Microplastics and nanoplastics (MNPs) are emerging as a potential risk factor for cardiovascular disease in preclinical studies. Direct evidence that this risk extends to humans is lacking.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo

Cite This Study

Marfella et al. (Wed,) studied this question.

synapsesocial.com/papers/68e75683b6db6435876ce2e9 https://doi.org/https://doi.org/10.1056/nejmoa2309822

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Bioavailability and biodistribution of differently charged polystyrene nanoparticles upon oral exposure in rats2015 · 192 citations
2Suspended fine particulate matter (PM2.5), microplastics (MPs), and polycyclic aromatic hydrocarbons (PAHs) in air: Their possible relationships and health implications2020 · 454 citations
3Serum interleukin-6 is elevated in symptomatic carotid bifurcation disease2008 · 35 citations
4Reanalysis of updated mortality among vinyl and polyvinyl chloride workers: Confirmation of historical evidence and new findings2008 · 64 citations
5Cardiovascular toxicity assessment of polyethylene nanoplastics on developing zebrafish embryos2021 · 163 citations

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo